Università Vita-salute San Raffaele
Clinical trials sponsored by Università Vita-salute San Raffaele, explained in plain language.
-
Anti-scarring drug may help lungs heal faster in ICU patients
Disease control Recruiting nowThis study tests whether pirfenidone, a drug already used for lung scarring, can prevent fibrosis in patients with severe breathing failure (ARDS). About 130 adults on ventilators will receive either pirfenidone or a placebo. The goal is to see if the drug helps them spend fewer …
Phase: PHASE3 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 17, 2026 01:44 UTC
-
Heart drug during surgery may cut deadly complication risk
Disease control Recruiting nowThis study tests if adding the drug landiolol to the fluid that protects the heart during mitral valve surgery can reduce a serious complication called low cardiac output syndrome, where the heart struggles to pump enough blood after surgery. About 1500 adults having elective mit…
Phase: PHASE4 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Could a scan replace surgery for breast cancer staging?
Diagnosis Recruiting nowThis study tests whether a special PET/MRI scan can accurately detect if breast cancer has spread to lymph nodes in the armpit, potentially replacing the need for surgical removal of those nodes. About 119 women with certain types of breast cancer (luminal A or lobular) will get …
Phase: PHASE2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Diagnosis
Last updated Jun 16, 2026 12:54 UTC
-
Could ketamine make shock therapy safer and more effective for depression?
Symptom relief Recruiting nowThis study tests whether adding ketamine to electroconvulsive therapy (ECT) helps people with severe, treatment-resistant depression feel better and have fewer memory problems. Thirty hospitalized adults will receive either ketamine or a placebo during three ECT sessions. The goa…
Phase: PHASE3 • Sponsor: Università Vita-Salute San Raffaele • Aim: Symptom relief
Last updated Jun 15, 2026 18:56 UTC
-
Massive COVID-19 biobank aims to unlock secrets of severe disease
Knowledge-focused Recruiting nowThis study is collecting medical information and biological samples from up to 6,000 people with COVID-19. Researchers want to find out which factors predict severe illness, death, or response to treatment. The goal is to better understand the disease and help guide future care.
Sponsor: Università Vita-Salute San Raffaele • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:09 UTC
-
Could a simple device let bystanders save lives in breathing emergencies?
Knowledge-focused Recruiting nowThis study tests a new portable CPAP device designed to help people with sudden breathing failure before they reach the hospital. Researchers want to see if the device is easy enough for non-medical people to use correctly. The study involves 50 participants: healthy older adults…
Phase: NA • Sponsor: Università Vita-Salute San Raffaele • Aim: Knowledge-focused
Last updated Jun 02, 2026 11:56 UTC